Clinical trials
Osteoporosis in Post-menopausal Women clinical trials
Below are recruiting osteoporosis in post-menopausal women clinical trials, each written for real people, not researchers. We’re tracking 8 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07401381RecruitingPhase 1
Injectable vs. oral letrozole in early breast cancer
This study compares a new injectable form of the drug letrozole with the standard oral pill. It aims to find out if the injection works as well as the pill for women who have already taken letrozole for their early breast cancer and have finished their initial treatment.
Beverly Hills, CaliforniaAges 18–80 - NCT06864130RecruitingPhase 4
Stopping Alendronate in osteoporosis after no fractures
This study wants to see if it is safe for postmenopausal women with osteoporosis to stop taking Alendronate after a long period of treatment without any new fractures. If you have been on Alendronate for a while and have stayed fracture-free, you may be able to take a break from the medicine.
AalborgAges Any age - NCT06741956Enrolling by invitation
Wearable device for osteoporosis prevention in women
This trial tests a wearable device designed to help prevent osteoporosis and reduce fracture risk in women who have recently gone through menopause. The goal is to see if the device can help you stay active and lower your chances of breaking a bone.
Seville, SpainAges 40 years+ - NCT06364267RecruitingPhase 2
Low dose exemestane vs low dose tamoxifen for breast cancer prevention
This trial compares two low-dose medications, exemestane and tamoxifen, to see which is better at preventing breast cancer in postmenopausal women who have a higher risk. You would take one of these pills daily for a few years, and the study will check how well it works and what side effects occur.
Genova, ItalyAges Any age - NCT05571514Recruiting
Pearl supplement study to help prevent menopause-related bone loss
This study tests whether a “mother-of-pearl” nutritional supplement can help prevent osteoporosis after menopause. You may qualify if you’re a post-menopausal woman with lower-than-normal bone density but without past fragility fractures.
Clermont-FerrandAges 50–65 - NCT05590949Recruiting
Bone health study for breast cancer survivors off bone medication
This study looks at bone complications in women who have finished treatment with denosumab (a bone-strengthening drug) and aromatase inhibitors (hormone therapy for breast cancer). It aims to learn more about what happens to bones after stopping these medications, which may help guide future care.
Basking Ridge, New JerseyAges 18 years+ - NCT05478083RecruitingPhase 2
Leuprolide treatment for severe polycystic liver growth
This Phase 2 study tests whether a monthly hormone medicine (leuprolide, a GnRH agonist given as an injection) can slow down ongoing, fast-growing polycystic livers. It is aimed at pre-menopausal women with very large livers that are still getting bigger on past and current scans.
Nijmegen, GelderlandAges 18–45 - NCT06767150RecruitingPhase 4
Bone treatment after stopping denosumab for osteoporosis
This trial tests whether giving zoledronic acid (a bone-strengthening infusion) right after stopping denosumab can help prevent bone loss in women with post-menopausal osteoporosis. It may be a good option if you have finished at least 2 years of denosumab and your doctor says it's safe to stop.
AmiensAges 18 years+
Hear when a new Osteoporosis in Post-menopausal Women trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for osteoporosis in post-menopausal women?
- Yes. Clin2 currently lists 8 recruiting osteoporosis in post-menopausal women studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a osteoporosis in post-menopausal women trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a osteoporosis in post-menopausal women trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.